Article
Screening for Symptomatic Mefloquine Exposure Among Veterans With Chronic Psychiatric Symptoms
Mefloquine is an antimalarial drug that is associated with a significant risk of chronic neuropsychiatric adverse effects (AEs). The drug was...
Article
FDA Black Box, VA Red Ink? A Successful Service-Connected Disability Claim for Chronic Neuropsychiatric Adverse Effects From Mefloquine
More veterans are likely to present to the VA with service-connected claims for adverse effects related to exposure to a prophylactic antimalarial...